Quality of Pharmacist-Managed Anticoagulation Therapy in Long-Term Ambulatory Settings: A Systematic Review von Manzoor, Beenish S., Cheng, Wei-Han, Lee, James C., Uppuluri, Ellen M., Nutescu, Edith A.

Volltext

Real‐world comparative effectiveness of venetoclax‐obinutuzumab versus Bruton tyrosine kinase inhibitors for frontline chronic lymphocytic leukaemia von Ghosh, Nilanjan, Manzoor, Beenish S., Fakhri, Bita, Emechebe, Nnadozie, Alhasani, Hasan, Skarbnik, Alan, Jawaid, Dureshahwar, Shadman, Mazyar

Volltext

Drug-Alcohol Interactions in Older U.S. Adults von Qato, Dima Mazen, Manzoor, Beenish S., Lee, Todd A.

Volltext

Real‐World Adherence and Persistence with Direct Oral Anticoagulants in Adults with Atrial Fibrillation von Manzoor, Beenish S., Lee, Todd A., Sharp, Lisa K., Walton, Surrey M., Galanter, William L., Nutescu, Edith A.

Volltext

Cost-effectiveness of a 12-month fixed-duration venetoclax treatment in combination with obinutuzumab in first-line, unfit chronic lymphocytic leukemia in the United States von Chatterjee, Anuja, Shapouri, Sheila, Manzoor, Beenish S., Ravelo, Arliene, Sail, Kavita, Qendri, Venetia, van de Wetering, Gijs, Davids, Matthew S.

Volltext

The Economic Impact of Treatment Sequencing in Chronic Lymphocytic Leukemia in Canada Using Venetoclax plus Obinutuzumab von Guinan, Kimberly, Mathurin, Karine, Lachaine, Jean, Roc, Nancy Paul, Bull, Sarah-Jane, Tankala, Dipti, Barakat, Stephane, Manzoor, Beenish S, Hillis, Christopher, Banerji, Versha

Volltext

Real-world comparison of health care costs of venetoclax-obinutuzumab vs Bruton’s tyrosine kinase inhibitor use among US Medicare beneficiaries with chronic lymphocytic leukemia in... von Huntington, Scott F., Manzoor, Beenish S., Jawaid, Dureshahwar, Puckett, Justin T., Emechebe, Nnadozie, Ravelo, Arliene, Kamal-Bahl, Sachin, Doshi, Jalpa A.

Volltext

Budget Impact of 12-Month Fixed Treatment Duration Venetoclax in Combination with Obinutuzumab in Previously Untreated Chronic Lymphocytic Leukemia Patients in the United States von Cho, Sang Kyu, Manzoor, Beenish S., Sail, Kavita R., Parisé, Hélène, Ravelo, Arliene, Shapouri, Sheila, Kapustyan, Tatyana, Sharmokh, Simon, Virabhak, Suchin, Davids, Matthew S., Johnson, Scott

Volltext

Facilitators and Barriers to the Adoption of Pharmacogenetic Testing in an Inner‐City Population von Lee, Yee Ming, Manzoor, Beenish S., Cavallari, Larisa H., Nutescu, Edith A.

Volltext

A Probabilistic Cost-Effectiveness Analysis of Venetoclax and Obinutuzumab as a First-Line Therapy in Chronic Lymphocytic Leukemia in Canada von Chatterjee, Anuja, van de Wetering, Gijs, Goeree, Ron, Owen, Carolyn, Desbois, Anne Marie, Barakat, Stephane, Manzoor, Beenish S., Sail, Kavita

Volltext

CLL-410 Adherence and Discontinuation Among Medicare Beneficiaries Initiating Venetoclax versus BTKis for Relapsed/Refractory Chronic Lymphocytic Leukemia von Huntington, Scott F, Manzoor, Beenish S, Puckett, Justin T, Kamal-Bahl, Sachin, Alhasani, Hasan, Ravelo, Arliene, Fuldeore, Mahesh, Doshi, Jalpa A

Volltext

High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy von Manzoor, Beenish S., Walton, Surrey M., Sharp, Lisa K., Galanter, William L., Lee, Todd A., Nutescu, Edith A.

Volltext

Treatment Discontinuation Patterns for Patients With Chronic Lymphocytic Leukemia in Real-World Settings: Results From a Multi-Center International Study von Shadman, Mazyar, Manzoor, Beenish S., Sail, Kavita, Tuncer, Hande H., Allan, John N., Ujjani, Chaitra, Emechebe, Nnadozie, Kamalakar, Rajesh, Coombs, Catherine C., Leslie, Lori, Barr, Paul M., Brown, Jennifer R., Eyre, Toby A., Rampotas, Alexandros, Schuh, Anna, Lamanna, Nicole, Skarbnik, Alan, Roeker, Lindsey E., Bannerji, Rajat, Eichhorst, Barbara, Fleury, Isabelle, Davids, Matthew S., Alhasani, Hasan, Jiang, Dingfeng, Hill, Brian T., Schuster, Stephen J., Brander, Danielle M., Pivneva, Irina, Burne, Rebecca, Guerin, Annie, Mato, Anthony R.

Volltext

Comparative Effectiveness of Patient-centered Strategies to Improve FDA Medication Guides von Wolf, Michael S., Bailey, Stacy C., Serper, Marina, Smith, Meredith, Davis, Terry C., Russell, Allison L., Manzoor, Beenish S., Belter, Lisa, Parker, Ruth M., Lambert, Bruce

Volltext

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen von Thompson, Meghan C., Harrup, Rosemary A., Coombs, Catherine C., Roeker, Lindsey E., Pu, Jeffrey J., Choi, Michael Y., Barr, Paul M., Allan, John N., Šimkovič, Martin, Leslie, Lori, Rhodes, Joanna, Chong, Elise A., Kamdar, Manali, Skarbnik, Alan, Lansigan, Frederick, McCall, Brittany, Saja, Khalid, Dyer, Martin J.S., Walter, Harriet S., Lefebure, Marcus, Thadani-Mulero, Maria, Boyer, Michelle, Biondo, Juliana, Sail, Kavita, Manzoor, Beenish S., Furman, Richard, Bantilan, Kurt S., Goy, Andre, Feldman, Tatyana, Labella, Dominic, Schuster, Stephen J., Park, Jae, Palomba, Lia, Zelenetz, Andrew, Eyre, Toby A., Kater, Arnon P., Seymour, John F., Mato, Anthony R.

Volltext

Outcomes of systematic anticoagulation management in pharmacist and nurse specialized clinics von Manzoor, Beenish S., Bauman, Jerry, Shapiro, Nancy L., Stamos, Thomas, Galanter, William, Nutescu, Edith A.

Volltext

P648: REAL‐WORLD TREATMENT AND OUTCOMES OF PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) RECEIVING FIRST‐LINE (1L) THERAPY IN THE NOVEL AGENT ERA: AN INTERNATIONAL STUDY von Lansigan, Frederick, A. Eyre, Toby, Ghosh, Nilanjan, S. Manzoor, Beenish, C. Coombs, Catherine, Lamanna, Nicole, H. Tuncer, Hande, Emechebe, Dozie, R. Brown, Jennifer, E. Roeker, Lindsey, Ujjani, Chaitra, Alhasani, Hasan, Fleury, Isabelle, A. Leslie, Lori, Skarbnik, Alan, Rhodes, Joanna, T. Hill, Brian, M. Barr, Paul, S. Davids, Matthew, P. Fox, Christopher, Choi, Yun, Schuh, Anna, Kennard, Kaitlin, E. Jensen, Christopher, Jawaid, Dureshahwar, Sharma, Aditya, Pivneva, Irina, Watson, Talissa, Shadman, Mazyar

Volltext

P647: RACIAL DISPARITIES IN REAL‐WORLD TREATMENT PATTERNS AND OUTCOMES AMONG PATIENTS WITH CLL von Rhodes, Joanna, Shadman, Mazyar, Lamanna, Nicole, S. Manzoor, Beenish, Coombs, Catherine, Ghosh, Nilanjan, H. Tuncer, Hande, Emechebe, Dozie, R. Brown, Jennifer, Alhasani, Hasan, Leslie, Lori, Roeker, Lindsey, Ujjani, Chaitra, Eichhorst, Barbara, Fleury, Isabelle, Skarbnik, Alan, T. Hill, Brian, Lansigan, Frederick, M. Barr, Paul, Davids, Matthew, Fox, Christopher, Choi, Yun, E. Jensen, Christopher, Schuh, Anna, Kennard, Kaitlin, Jawaid, Dureshahwar, Pivneva, Irina, Watson, Talissa, Eyre, Toby

Volltext

Understanding Patient Preferences for Chronic Lymphocytic Leukemia Treatments von Ravelo, Arliene, Myers, Kelley, Brumble, Robyn, Bussberg, Cooper, Koffman, Brian, Manzoor, Beenish S., Biondo, Juliana, Mansfield, Carol

Volltext

Real-World Comparison of Healthcare Costs of Venetoclax-Obinutuzumab Vs. Btki Use Among Elderly U.S. Medicare Beneficiaries with Chronic Lymphocytic Leukemia in the Front-Line (1L)... von Manzoor, Beenish S, Huntington, Scott F., Jawaid, Dureshahwar, Puckett, Justin T., Emechebe, Nnadozie, Ravelo, Arliene, Kamal-Bahl, Sachin, Doshi, Jalpa A.

Volltext